antiprimod has been researched along with Lymphoma, Mantle-Cell in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (50.00) | 29.6817 |
| 2010's | 1 (50.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Dong, W; Qian, J; Sun, L; Wang, M; Yang, J; Yi, Q; Zhang, L | 1 |
| Han, X; Hong, S; Qian, J; Romaguera, J; Samaniego, F; Wang, M; Yang, J; Yi, Q; Zhang, L | 1 |
2 other study(ies) available for antiprimod and Lymphoma, Mantle-Cell
| Article | Year |
|---|---|
Combination of atiprimod and the proteasome inhibitor bortezomib induces apoptosis of mantle cell lymphoma in vitro and in vivo.
Topics: Animals; Antineoplastic Agents; Apoptosis; Apoptosis Inducing Factor; Blotting, Western; Boronic Acids; Bortezomib; Cell Line, Tumor; Cell Proliferation; Drug Synergism; Humans; In Vitro Techniques; Leukocytes, Mononuclear; Lymphoma, Mantle-Cell; Male; Mice; Mice, Inbred NOD; Mice, SCID; Pyrazines; Spiro Compounds; Survival Rate | 2012 |
Atiprimod inhibits the growth of mantle cell lymphoma in vitro and in vivo and induces apoptosis via activating the mitochondrial pathways.
Topics: Animals; Apoptosis; Apoptosis Regulatory Proteins; Cell Proliferation; Drug Evaluation, Preclinical; Lymphoma, Mantle-Cell; Mice; Mitochondria; Mitochondrial Proteins; Spiro Compounds | 2007 |